Institute of Nephrology, 26743Shaare Zedek Medical Center, Affiliated with the Hebrew University, Jerusalem, Israel.
Infectious Diseases Unit, 26743Shaare Zedek Medical Center, Affiliated with the Hebrew University, Jerusalem, Israel.
Perit Dial Int. 2021 May;41(3):284-291. doi: 10.1177/0896860820923461. Epub 2020 May 13.
Nontuberculous mycobacteria (NTM) infections pose a diagnostic challenge in peritoneal dialysis (PD) patients. In this study, we sought to identify findings that are suggestive of NTM infection in PD adult patients.
All patients with NTM exit-site infection (ESI) with/without tunnel infection and peritonitis identified during the last decade in eight medical centers in Israel were included. Clinical, microbiological, and outcome data were collected and analyzed.
Thirty patients were identified; 16 had ESI (53%) and 14 had peritonitis (47%). Median age was 65 years (interquartile range 52-76). Abdominal pain and cloudy PD fluid were reported in all patients with peritonitis, whereas exit-site discharge and granulation tissue were common in patients with ESI. Fourteen patients (47%) had negative cultures prior NTM diagnosis, and isolation of diphtheroids or was reported in 9 of 30 patients (30%). Antimicrobial treatment prior to diagnosis was documented in 13 of 30 patients (43%). Delayed diagnosis was frequent. Treatment regimens and duration of therapy varied widely. In 26 of 30 (87%) patients, catheter was removed and 19 of 30 patients (63%) required permanent transition to hemodialysis. Two patients with peritonitis (2 of 14, 14%) and seven with ESI (7 of 16, 44%) were eligible for continuation of PD.
Culture negative peritonitis, isolation of diphtheroids or ., previous exposure to antibiotics, and/or a refractory infection should all prompt consideration of PD-related NTM infection and timely workup. Catheter removal is recommended aside prolonged antimicrobial therapy. In select patients with ESI, continuation of PD may be feasible.
非结核分枝杆菌(NTM)感染给腹膜透析(PD)患者的诊断带来了挑战。本研究旨在确定提示 PD 成年患者 NTM 感染的特征。
纳入过去十年在以色列 8 家医疗中心发现的所有伴/不伴隧道感染的 NTM 出口部位感染(ESI)和腹膜炎的患者。收集并分析临床、微生物学和转归数据。
共 30 例患者,其中 16 例 ESI(53%)和 14 例腹膜炎(47%)。中位年龄为 65 岁(四分位间距 52-76)。所有腹膜炎患者均有腹痛和混浊的 PD 液,而 ESI 患者常见出口部位分泌物和肉芽组织。14 例(47%)患者在 NTM 诊断前的培养结果为阴性,30 例患者中有 9 例(30%)报告分离出类白喉菌或 。30 例患者中有 13 例(43%)在诊断前有接受过抗菌药物治疗。诊断延迟较为常见。治疗方案和治疗持续时间差异很大。在 30 例患者中有 26 例(87%)患者拔除了导管,30 例患者中有 19 例(63%)需要永久性转为血液透析。2 例腹膜炎患者(14%,2 例)和 7 例 ESI 患者(44%,7 例)适合继续 PD。
阴性培养的腹膜炎、分离出类白喉菌或 、先前暴露于抗生素和/或难治性感染,均应提示与 PD 相关的 NTM 感染,并及时进行检查。建议在延长抗菌治疗的同时拔除导管。对于少数 ESI 患者,继续 PD 可能是可行的。